Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 1
1996 2
1997 6
1998 4
1999 1
2002 3
2004 2
2005 1
2006 2
2008 1
2009 3
2010 1
2011 2
2012 2
2013 3
2014 5
2015 4
2016 4
2017 4
2018 9
2019 4
2020 3
2021 3
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators. Tashkin DP, et al. Among authors: kleerup ec. Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25. Lancet Respir Med. 2016. PMID: 27469583 Free PMC article. Clinical Trial.
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.
Madapoosi SS, Cruickshank-Quinn C, Opron K, Erb-Downward JR, Begley LA, Li G, Barjaktarevic I, Barr RG, Comellas AP, Couper DJ, Cooper CB, Freeman CM, Han MK, Kaner RJ, Labaki W, Martinez FJ, Ortega VE, Peters SP, Paine R, Woodruff P, Curtis JL, Huffnagle GB, Stringer KA, Bowler RP, Esther CR Jr, Reisdorph N, Huang YJ; SPIROMICS Research Group. Madapoosi SS, et al. Am J Respir Crit Care Med. 2022 Aug 15;206(4):427-439. doi: 10.1164/rccm.202110-2241OC. Am J Respir Crit Care Med. 2022. PMID: 35536732
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
Hastie AT, Martinez FJ, Curtis JL, Doerschuk CM, Hansel NN, Christenson S, Putcha N, Ortega VE, Li X, Barr RG, Carretta EE, Couper DJ, Cooper CB, Hoffman EA, Kanner RE, Kleerup E, O'Neal WK, Paine R 3rd, Peters SP, Alexis NE, Woodruff PG, Han MK, Meyers DA, Bleecker ER; SPIROMICS investigators. Hastie AT, et al. Lancet Respir Med. 2017 Dec;5(12):956-967. doi: 10.1016/S2213-2600(17)30432-0. Epub 2017 Nov 13. Lancet Respir Med. 2017. PMID: 29146301 Free PMC article.
Repeatability of Pulmonary Quantitative Computed Tomography Measurements in Chronic Obstructive Pulmonary Disease.
Motahari A, Barr RG, Han MK, Anderson WH, Barjaktarevic I, Bleecker ER, Comellas AP, Cooper CB, Couper DJ, Hansel NN, Kanner RE, Kazerooni EA, Lynch DA, Martinez FJ, Newell JD Jr, Schroeder JD, Smith BM, Woodruff PG, Hoffman EA; SPIROMICS Group. Motahari A, et al. Am J Respir Crit Care Med. 2023 Sep 15;208(6):657-665. doi: 10.1164/rccm.202209-1698PP. Am J Respir Crit Care Med. 2023. PMID: 37490608 Free PMC article. No abstract available.
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.
Opron K, Begley LA, Erb-Downward JR, Li G, Alexis NE, Barjaktarevic I, Barr RG, Bleecker ER, Boucher R, Bowler RP, Christenson SA, Comellas AP, Criner G, Cooper CB, Couper D, Galban CJ, Han MK, Hastie A, Hatt C, Hoffman EA, Kaner RJ, Kesimer M, Krishnan JA, LaFon DC, Martinez FJ, Ortega VE, Peters SP, Paine R 3rd, Putcha N, Woodruff PG, Huffnagle GB, Kozik AJ, Curtis JL, Huang YJ; SPIROMICS Investigators. Opron K, et al. Am J Respir Crit Care Med. 2024 Jul 15;210(2):186-200. doi: 10.1164/rccm.202303-0489OC. Am J Respir Crit Care Med. 2024. PMID: 38261629
Vessel and Airway Characteristics in One-Year Computed Tomography-defined Rapid Emphysema Progression: SPIROMICS.
Gerard SE, Dougherty TM, Nagpal P, Jin D, Han MK, Newell JD Jr, Saha PK, Comellas AP, Cooper CB, Couper D, Fortis S, Guo J, Hansel NN, Kanner RE, Kazeroni EA, Martinez FJ, Motahari A, Paine R 3rd, Rennard S, Schroeder JD, Woodruff PG, Barr RG, Smith BM, Hoffman EA; SPIROMICS Research Group. Gerard SE, et al. Ann Am Thorac Soc. 2024 Jul;21(7):1022-1033. doi: 10.1513/AnnalsATS.202304-383OC. Ann Am Thorac Soc. 2024. PMID: 38530051
HIV and chronic obstructive pulmonary disease: is it worse and why?
Morris A, George MP, Crothers K, Huang L, Lucht L, Kessinger C, Kleerup EC; Lung HIV Study. Morris A, et al. Among authors: kleerup ec. Proc Am Thorac Soc. 2011 Jun;8(3):320-5. doi: 10.1513/pats.201006-045WR. Proc Am Thorac Soc. 2011. PMID: 21653535 Free PMC article. Review.
Asthma type A...Z.
Kleerup EC. Kleerup EC. Curr Opin Pulm Med. 2002 Jan;8(1):1-3. doi: 10.1097/00063198-200201000-00001. Curr Opin Pulm Med. 2002. PMID: 11753116 No abstract available.
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
Fortis S, Quibrera PM, Comellas AP, Bhatt SP, Tashkin DP, Hoffman EA, Criner GJ, Han MK, Barr RG, Arjomandi M, Dransfield MB, Peters SP, Dolezal BA, Kim V, Putcha N, Rennard SI, Paine R 3rd, Kanner RE, Curtis JL, Bowler RP, Martinez FJ, Hansel NN, Krishnan JA, Woodruff PG, Barjaktarevic IZ, Couper D, Anderson WH, Cooper CB; Subpopulations and Intermediate Outcome Measures in COPD Study Investigators. Fortis S, et al. Chest. 2023 Mar;163(3):502-514. doi: 10.1016/j.chest.2022.11.009. Epub 2022 Nov 15. Chest. 2023. PMID: 36395858 Free PMC article.
Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD.
Esther CR Jr, O'Neal WK, Anderson WH, Kesimer M, Ceppe A, Doerschuk CM, Alexis NE, Hastie AT, Barr RG, Bowler RP, Wells JM, Oelsner EC, Comellas AP, Tesfaigzi Y, Kim V, Paulin LM, Cooper CB, Han MK, Huang YJ, Labaki WW, Curtis JL, Boucher RC; Subpopulations and Intermediate Outcome Measures in COPD Study. Esther CR Jr, et al. Chest. 2022 May;161(5):1239-1249. doi: 10.1016/j.chest.2021.10.049. Epub 2021 Nov 18. Chest. 2022. PMID: 34801592 Free PMC article.
76 results